{"transactions":[{"id":2229507,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2022-06-16T16:01:21.000Z","date":"2022-06-14","kind":"other","acquired":false,"shares":61111,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2015-06-15","expiration_date":"2022-06-15","underlying":"Common Stock","underlying_shares":61111},"source":{"system":"sec-edgar","filing":"0001209191-22-037394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919122037394/doc4.xml","form_type":"4"}},{"id":2229506,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T16:01:21.000Z","date":"2022-06-14","kind":"tax_withholding","acquired":false,"shares":51562,"price":3.2,"value":164998.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2022, the reporting person exercised a warrant to purchase 61,111 shares of the Issuers common stock for $2.70 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer withholding of 51,562 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 9,549 shares."}],"balance_after":687049,"source":{"system":"sec-edgar","filing":"0001209191-22-037394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919122037394/doc4.xml","form_type":"4"}},{"id":2229505,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T16:01:21.000Z","date":"2022-06-14","kind":"other","acquired":true,"shares":61111,"price":2.7,"value":164999.7,"ownership":{"direct":true},"balance_after":738611,"source":{"system":"sec-edgar","filing":"0001209191-22-037394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919122037394/doc4.xml","form_type":"4"}},{"id":2442798,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T20:21:27.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2022.  The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.28,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-001045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924322001045/doc4.xml","form_type":"4"}},{"id":2888251,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T17:41:22.000Z","date":"2020-12-02","kind":"gift","acquired":true,"shares":271000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Julie Heider Nongrantor Pot Trust under the Julie Heider 2020 Irrevocable Trust"},"balance_after":271000,"source":{"system":"sec-edgar","filing":"0000899243-21-003885","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924321003885/doc5.xml","form_type":"5"}},{"id":2888250,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T17:41:22.000Z","date":"2020-12-02","kind":"gift","acquired":true,"shares":162600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust"},"balance_after":162600,"source":{"system":"sec-edgar","filing":"0000899243-21-003885","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924321003885/doc5.xml","form_type":"5"}},{"id":2888249,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T17:41:22.000Z","date":"2020-12-02","kind":"gift","acquired":true,"shares":162600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Extended Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust"},"balance_after":162600,"source":{"system":"sec-edgar","filing":"0000899243-21-003885","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924321003885/doc5.xml","form_type":"5"}},{"id":2888248,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T17:41:22.000Z","date":"2020-12-02","kind":"gift","acquired":false,"shares":596200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81300,"source":{"system":"sec-edgar","filing":"0000899243-21-003885","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924321003885/doc5.xml","form_type":"5"}},{"id":2914643,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T16:39:08.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":12.36,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-000701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924321000701/doc4.xml","form_type":"4"}},{"id":3018132,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T16:13:34.000Z","date":"2020-09-30","kind":"purchase","acquired":true,"shares":5000,"price":15.3,"value":76500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.20 to $15.30, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":677500,"source":{"system":"sec-edgar","filing":"0000899243-20-026662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924320026662/doc4.xml","form_type":"4"}},{"id":3018131,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T16:13:34.000Z","date":"2020-09-29","kind":"purchase","acquired":true,"shares":5000,"price":15,"value":75000.0,"ownership":{"direct":true},"balance_after":672500,"source":{"system":"sec-edgar","filing":"0000899243-20-026662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000089924320026662/doc4.xml","form_type":"4"}},{"id":3317490,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-06T17:54:17.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy."}],"balance_after":8000,"derivative":{"exercise_price":16.31,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-20-002058","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919120002058/doc4.xml","form_type":"4"}},{"id":3685113,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2019-01-28T16:40:41.000Z","date":"2017-12-29","kind":"other","acquired":true,"shares":192495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the initial public offering of the Issuer, the Warrants were issued to MDB Capital Group LLC (\"MDB\") as partial consideration for services as underwriter. MDB assigned a portion of the Warrants to the reporting person effective December 29, 2017."}],"balance_after":192495,"derivative":{"exercise_price":9.375,"exercise_date":"2018-06-12","expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":192495},"source":{"system":"sec-edgar","filing":"0001209191-19-005543","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919119005543/doc4.xml","form_type":"4"}},{"id":3707364,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-03T18:37:37.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":5.16,"exercise_date":"2020-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-001326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919119001326/doc4.xml","form_type":"4"}},{"id":3860963,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-07-26T20:00:17.000Z","date":"2018-07-19","kind":"other","acquired":true,"shares":504668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon closing of the initial public offering of Provention Bio, Inc., a warrant was issued to MDB Capital Group LLC as partial consideration for services related to the offering. MDB Capital Group assigned a portion of that warrant to reporting person effective July 19, 2018."}],"balance_after":504668,"derivative":{"exercise_price":5,"exercise_date":"2019-06-28","expiration_date":"2023-07-03","underlying":"Common Stock, par value $0.0001","underlying_shares":504668},"source":{"system":"sec-edgar","filing":"0001493152-18-010543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218010543/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-19"}},{"id":3864588,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-07-19T17:56:50.000Z","date":"2018-07-19","kind":"exercise","acquired":true,"shares":144824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"As previously reported on reporting person's Form 3 filed on July 3, 2018, upon consummation of the initial public offering of Provention Bio, Inc. (the \"Issuer\"), which closed on July 19, 2018, each share of Series A Preferred Stock will automatically convert into one share of Common Stock, par value $0.0001 per share (\"Common Stock\") and the Warrant will automatically convert into a warrant to purchase Common Stock."}],"balance_after":144824,"derivative":{"exercise_price":2.5,"exercise_date":"2017-04-25","expiration_date":"2024-04-25","underlying":"Common Stock, par value $0.0001","underlying_shares":144824},"source":{"system":"sec-edgar","filing":"0001493152-18-010235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218010235/ownership.xml","form_type":"4"}},{"id":3864587,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2018-07-19T17:56:50.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":128981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's 2017 Equity Incentive Plan, effective as of the closing of the Issuer's initial public offering of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in eight equal semi-annual installments commencing on January 19, 2018 and will become fully vested on July 19, 2022."}],"balance_after":128981,"derivative":{"exercise_price":4,"expiration_date":"2028-07-19","underlying":"Common Stock, par value $0.0001","underlying_shares":128981},"source":{"system":"sec-edgar","filing":"0001493152-18-010235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315218010235/ownership.xml","form_type":"4"}},{"id":3893416,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":126086,"kind":"person","name":"Gray Cameron","position":1,"cik":"0001590583","reported_name":"Gray Cameron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T17:34:58.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":14.24,"exercise_date":"2018-12-31","expiration_date":"2025-06-12","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-037811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590583/000120919118037811/doc4.xml","form_type":"4"}}]}